Professor Jamshed Bomanji

Dr Jamshed BomanjiTel: 020 3447 0528
Fax: 020 3447 9407
Email: jamshed.bomanji@nhs.net

Location:
University College Hospital

Specialities:
Nuclear medicine

Professional background

Dr. Jamshed Bomanji, graduated in 1980. Jamshed did his post-graduation at St Bartholomew’s Hospital where he completed his Masters and PhD in Nuclear Medicine in 1987. He was appointed as Consultant in Nuclear Medicine at St Bartholomew’s Hospital in 1990 and then moved to The Middlesex Hospital in 1993, which is now part of the UCLH NHS Foundation Trust. Currently, he is the Clinical Lead and Head of Department at the Institute of Nuclear Medicine which is the largest single site department in UK. He has contributed and published more than 142 research and clinical papers in peer reviewed Journals, authored 20 book Chapters and is the editor of Nuclear Medicine in Oncology. He is assistant editor and advisory editor of various Journals in the field of Nuclear Medicine.

Research interests

His main interests are in the diagnostic and therapeutic application of Nuclear Medicine techniques in Oncology, Nephrology/Urology, Cardiology and Neurology for benign and malignant disease.

Publications

Some recent publications:  Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. J Nucl Med. 2009 Dec;50(12):1927-32. 
 
Lambert JR, Bomanji JB, Peggs KS, Thomson KJ, Chakraverty RK, Fielding AK, Kottaridis PD, Roughton M, Morris EC, Goldstone AH, Linch DC, Ell PJ, Mackinnon S. Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. Blood. 2010 Apr 8;115(14):2763-8.  
 
Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med. 2010 Jun;51(6):875-82.    
 
Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, Papathanasiou ND, Pepe G, Oyen W, De Cristoforo C, Chiti A. Procedure guidelines for PET/CT tumour imaging with (68)Ga-DOTA-conjugated peptides: (68)Ga-DOTA-TOC, (68)Ga-DOTA-NOC, (68)Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004-10.

GMC/GDC number: 2876984